Virtu Financial’s Aldeyra Therapeutics ALDX Stock Holding History

Virtu Financial’s Portfolio ALDX Stock Details ALDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-49,294	Closed	-$414K	–	1246
2023 Q2	$414K	Buy	+49,294	New	+$486K	0.03%	464
2022 Q4	–	Sell	-18,573	Closed	-$99K	–	1547
2022 Q3	$99K	Buy	+18,573	New	+$111K	0.01%	1085
2022 Q1	–	Sell	-32,401	Closed	-$130K	–	1459
2021 Q4	$130K	Buy	+32,401	New	+$247K	0.01%	1014
2021 Q3	–	Sell	-12,824	Closed	-$145K	–	1454
2021 Q2	$145K	Buy	+12,824	New	+$154K	0.01%	1105
2021 Q1	–	Sell	-13,428	Closed	-$92K	–	1557
2020 Q4	$92K	Sell	13,428 -14,896	-53%	-$105K	0.01%	1082
2020 Q3	$210K	Buy	+28,324	New	+$183K	0.04%	581
2019 Q4	$92K	Buy	+15,886	New	+$91.8K	0.01%	1097
2019 Q3	–	Sell	-15,932	Closed	-$96K	–	1399
2019 Q2	$96K	Buy	+15,932	New	+$120K	0.01%	1137
2018 Q4	–	Sell	-73,023	Closed	-$1.01M	–	1519
2018 Q3	$1.01M	Buy	73,023 +59,955	+459%	+$486K	0.06%	327
2018 Q2	$104K	Buy	+13,068	New	+$104K	0.01%	1637

Other funds holding ALDX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Virtu Financial's ALDX Position: Q3 2023 in Review

Virtu Financial sold out of Aldeyra Therapeutics (ALDX) in Q3 2023, closing a stake of 49,294 shares — an estimated $414K sold.

Virtu Financial first reported a position in ALDX in Q2 2018 and held it in 10 quarters. The position peaked at $1.01M in Q3 2018. 120 funds tracked by Wall St. Rank hold ALDX as of Q3 2023.

Virtu Financial reported no remaining Aldeyra Therapeutics position as of Q3 2023 after selling out during the quarter.
Virtu Financial sold 49,294 Aldeyra Therapeutics shares in Q3 2023, an estimated $414K.
Virtu Financial first reported a position in Aldeyra Therapeutics in Q2 2018 and held it in 10 quarters.
Virtu Financial's Aldeyra Therapeutics position peaked at $1.01M in Q3 2018.
120 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2023.

Based on Virtu Financial's 13F filing for Q3 2023, filed 15 Nov 2023.